Noninvasive Skin Spectroscopy for Diabetes Screening

Overview

The objective of this study is to assess the performance of a noninvasive device for the early screening of Diabetes Mellitus.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional

Detailed Description

Approximately 18 million people have Type II diabetes, and of these, an estimated thirty-five percent are unaware of their condition. This translates to roughly 6.3 million undiagnosed cases worldwide in 2002. Many diagnoses are made years after the onset of the disease. This allows progression of the vascular lesions that arise during the time of uncontrolled glucose levels. As a result, microvascular retinopathy, nephropathy, and neuropathy are on the rise, as well as macrovascular complications such as: coronary heart disease, and cerebral vascular accidents. The prevalence and trends of diabetes underscore the need for effective and widespread screening. Our fluorescence based system under development will noninvasively measure skin glycation end products that are known to be strongly correlated with diabetes status and complications. Since the test would be painless and require no patient fasting, significant obstacles to screening compliance would be mitigated. The system offers hope for a screening test that is more sensitive and specific than the invasive tests currently used for diabetes screening (Oral Glucose Tolerance Test (OGTT) and the Fasting Plasma Glucose (FPG) test).

Participating in This Clinical Trial

Inclusion Criteria

  • Volunteers without Diabetes. – Volunteers at risk for developing Type II diabetes. – 18 years of age and older. Exclusion Criteria:

  • Under 18 years of age. – Those diagnosed with Diabetes.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • InLight Solutions
  • Collaborator
    • VeraLight, Inc.
  • Overall Official(s)
    • Mark Rohrscheib, M.D., Principal Investigator, UNMHSC

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.